Literature DB >> 27098135

Dyslipidaemia: Evolocumab - alternative therapy in statin intolerance.

Dario Ummarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27098135     DOI： 10.1038/nrcardio.2016.72

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.

Authors:  Steven E Nissen; Erik Stroes; Ricardo E Dent-Acosta; Robert S Rosenson; Sam J Lehman; Naveed Sattar; David Preiss; Eric Bruckert; Richard Ceška; Norman Lepor; Christie M Ballantyne; Ioanna Gouni-Berthold; Mary Elliott; Danielle M Brennan; Scott M Wasserman; Ransi Somaratne; Rob Scott; Evan A Stein
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.